论文部分内容阅读
目的:探讨沙格列汀联合二甲双胍治疗初诊2型糖尿病的临床效果分析。方法:随机将88例在我院就诊的初诊2型糖尿病患者分为两组,44例为对照组,采用单纯二甲双胍治疗,观察组44例,采用沙格列汀联合二甲双胍治疗,对比两组疗效。结果:治疗后观察组患者空腹血糖、餐后2h血糖及糖化血红蛋白指标比较均优于对照组(p>0.05),两组患者治疗前后体质量比较均无较大差异(p>0.05),且两组患者在不良反应方面比较无较大差异(p>0.05)。结论:采用沙格列汀与二甲双胍联合的方式对初诊型2型糖尿病患者实施治疗效果显著,有利于改善患者血糖水平,且具有较高的安全性,可推广应用。
Objective: To investigate the clinical effect of paclitaxel combined with metformin in the treatment of newly diagnosed type 2 diabetes mellitus. Methods: A total of 88 patients with newly diagnosed type 2 diabetes who were treated in our hospital were randomly divided into two groups, 44 patients were treated with metformin alone and 44 patients in the observation group were treated with saxagliptin plus metformin. The curative effect was compared between the two groups . Results: After treatment, fasting blood glucose, postprandial 2h blood glucose and glycosylated hemoglobin were all better than the control group (p> 0.05). There was no significant difference in body mass between the two groups before and after treatment (p> 0.05) There was no significant difference in adverse reactions between the two groups (p> 0.05). Conclusion: The combination of saxagliptin and metformin has significant therapeutic effect on newly diagnosed type 2 diabetes patients, which is beneficial to improve blood sugar level of patients with high safety and can be popularized and applied.